Literature DB >> 25476859

Gold-phosphine-porphyrin as potential metal-based theranostics.

Semra Tasan1, Cynthia Licona, Pierre-Emmanuel Doulain, Clément Michelin, Claude P Gros, Pierre Le Gendre, Pierre D Harvey, Catherine Paul, Christian Gaiddon, Ewen Bodio.   

Abstract

Two new gold-phosphine-porphyrin derivatives were synthesized and fully characterized, and their photophysical properties investigated along a water-soluble analog. The cytotoxicity of the compounds was tested on cancer cells (HCT116 and SW480), and their cell uptake was followed by fluorescence microscopy in vitro (on SW480). The proof that the water-soluble gold-phosphine-porphyrin is a biologically active compound that can be tracked in vitro was clearly established, especially concerning the water-soluble analog. Some preliminary photodynamic therapy (PDT) experiments were also performed. They highlight a dramatic increase of the cytotoxicity when the cells were illuminated for 30 min with white light.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25476859     DOI: 10.1007/s00775-014-1220-8

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  29 in total

1.  Anthracene-tethered ruthenium(II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compounds.

Authors:  Alexey A Nazarov; Julie Risse; Wee Han Ang; Frederic Schmitt; Olivier Zava; Albert Ruggi; Michael Groessl; Rosario Scopelitti; Lucienne Juillerat-Jeanneret; Christian G Hartinger; Paul J Dyson
Journal:  Inorg Chem       Date:  2012-03-06       Impact factor: 5.165

Review 2.  Organometallic complexes: new tools for chemotherapy.

Authors:  N Chavain; C Biot
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  Metallodrugs in medicinal inorganic chemistry.

Authors:  Katja Dralle Mjos; Chris Orvig
Journal:  Chem Rev       Date:  2014-01-23       Impact factor: 60.622

4.  The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum.

Authors:  Declan Gaynor; Darren M Griffith
Journal:  Dalton Trans       Date:  2012-11-21       Impact factor: 4.390

5.  In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent.

Authors:  Taekwan Lee; Xiao-an Zhang; Shanta Dhar; Henryk Faas; Stephen J Lippard; Alan Jasanoff
Journal:  Chem Biol       Date:  2010-06-25

6.  A porphyrin complex of gold(I): (phosphine)gold(I) azides as cation precursors.

Authors:  David V Partyka; Thomas J Robilotto; Matthias Zeller; Allen D Hunter; Thomas G Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

Review 7.  New metal complexes as potential therapeutics.

Authors:  Christiana Xin Zhang; Stephen J Lippard
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

8.  Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.

Authors:  Angela Casini; Chiara Gabbiani; Francesca Sorrentino; Maria Pia Rigobello; Alberto Bindoli; Tilmann J Geldbach; Alessandro Marrone; Nazzareno Re; Christian G Hartinger; Paul J Dyson; Luigi Messori
Journal:  J Med Chem       Date:  2008-10-04       Impact factor: 7.446

Review 9.  The p53-mediated cytotoxicity of photodynamic therapy of cancer: recent advances.

Authors:  Joanna Zawacka-Pankau; Justyna Krachulec; Ireneusz Grulkowski; Krzysztof P Bielawski; Galina Selivanova
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-22       Impact factor: 4.219

10.  Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound.

Authors:  Alberta Bergamo; Alessia Masi; Paul J Dyson; Gianni Sava
Journal:  Int J Oncol       Date:  2008-12       Impact factor: 5.650

View more
  2 in total

Review 1.  Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment.

Authors:  Inés Mármol; Javier Quero; María Jesús Rodríguez-Yoldi; Elena Cerrada
Journal:  Cancers (Basel)       Date:  2019-06-05       Impact factor: 6.639

Review 2.  Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer.

Authors:  Fatima Dandash; David Y Leger; Mona Diab-Assaf; Vincent Sol; Bertrand Liagre
Journal:  Molecules       Date:  2021-11-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.